Bringing cell therapies to children
Rewriting how biotech works—faster, leaner and built for kids
Our MISSION
Cancers and other rare diseases are among the top 10 causes of death for children in the US, with an estimated 7,000 children lost every year.
Recent breakthroughs in cell therapy are transforming pediatric medicine, making cures once thought impossible now within reach.
- ACCESSforKIDS is a new model for biotech–designed for children, not markets. Our mission is to raise the capital, marshal the science, and build the infrastructure to rapidly move safe and effective cell and gene therapies from clinical trials to standard treatments, available to every child who can benefit.
Our leadership team
ACCESSforKIDS brings together cell therapy leaders and industry veterans to deliver life-saving treatments to children.
News
Enhancing pediatric access to cell and gene therapies
This perspective proposes the creation of a new entity, the Pediatric Advanced Medicines Biotech, to lead late-stage development and commercialize…
Enabling access to genetically modified cell therapies
This commentary outlines strategies to streamline regulatory pathways and enable timely, sustainable access to genetically modified cell therapies for small…
CAR T cells: improving outcomes for children with cancer
CAR T cells hold great promise for improving outcomes for children with cancer, but additional research and new business models…
Donate
From making fundamental research discoveries—to translating research into cures—your partnership makes positive change possible.
